Table 1 General characteristics of 320 metastatic PDAC patients
From: Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer
Characteristics | All patients (N = 320) | Elevated serum GGT (GGT > 48 U/L, N = 183) | Normal serum GGT (GGT ≤ 48 U/L, N = 137) | p value |
|---|---|---|---|---|
Mean (SD)/Median (SD)/N (%) | Mean (SD)/Median (SD)/N (%) | Mean (SD)/Median (SD)/N (%) | ||
Age at diagnosis (Years) | 65.28 (10.05) a | 65.93 (9.97) a | 64.41 (10.14) a | 0.18 |
Sex (Male) | 158 (49.38) c | 93 (50.82) c | 65 (47.45) c | 0.57 |
Palliative chemotherapy (Yes) | 150 (46.88) c | 63 (34.43) c | 87 (63.50) c | 10–6.5 |
Survival length (Days) | 177 (231.93) b | 138 (271.65) b | 281 (234.19) b | 10–6.0 |
Baseline serum indicators | ||||
ALB (g/L) | 37.00 (7.32) b | 36.00 (6.96) b | 39.30 (7.12) b | 10–6.5 |
TBIL (μmol/L) | 15.40 (113.14) b | 34.80 (137.81) b | 11.20 (15.36) b | 10−14 |
ALT (U/L) | 29.00 (107.87) b | 58.00 (110.61) b | 17.10 (91.23) b | 10–8.1 |
FPG (mmol/L) | 6.67 (3.26) b | 6.70 (3.78) b | 6.42 (2.32) b | 0.15 |
NLR (Unit free) | 4.46 (8.26) b | 5.08 (8.13) b | 3.74 (8.45) b | 10–2.3 |
GGT (U/L) | 85.5 (393.02) b | NA | NA | NA |